Two Sigma Investments’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.3K | Sell |
8,729
-138
| -2% | -$732 | ﹤0.01% | 3021 |
|
|
2025
Q1 | $39.2K | Sell |
8,867
-3,977
| -31% | -$17.6K | ﹤0.01% | 3007 |
|
|
2024
Q4 | $89.9K | Buy |
12,844
+1,316
| +11% | +$9.21K | ﹤0.01% | 2917 |
|
|
2024
Q3 | $167K | Buy |
11,528
+7,249
| +169% | +$105K | ﹤0.01% | 2764 |
|
|
2024
Q2 | $312K | Buy |
4,279
+1,770
| +71% | +$129K | ﹤0.01% | 2499 |
|
|
2024
Q1 | $149K | Buy |
+2,509
| New | +$149K | ﹤0.01% | 2706 |
|
|
2023
Q4 | – | Sell |
-6,456
| Closed | -$251K | – | 3324 |
|
|
2023
Q3 | $251K | Sell |
6,456
-480
| -7% | -$18.6K | ﹤0.01% | 2482 |
|
|
2023
Q2 | $400K | Buy |
6,936
+2,227
| +47% | +$128K | ﹤0.01% | 2342 |
|
|
2023
Q1 | $306K | Sell |
4,709
-373
| -7% | -$24.2K | ﹤0.01% | 2333 |
|
|
2022
Q4 | $140K | Buy |
5,082
+193
| +4% | +$5.31K | ﹤0.01% | 2398 |
|
|
2022
Q3 | $143K | Sell |
4,889
-538
| -10% | -$15.7K | ﹤0.01% | 2133 |
|
|
2022
Q2 | $104K | Buy |
+5,427
| New | +$104K | ﹤0.01% | 2198 |
|
|
2021
Q3 | – | Sell |
-1,632
| Closed | -$184K | – | 3017 |
|
|
2021
Q2 | $184K | Buy |
1,632
+322
| +25% | +$36.3K | ﹤0.01% | 2242 |
|
|
2021
Q1 | $198K | Buy |
+1,310
| New | +$198K | ﹤0.01% | 2174 |
|
|
2020
Q2 | – | Sell |
-1,773
| Closed | -$194K | – | 2411 |
|
|
2020
Q1 | $194K | Sell |
1,773
-2,362
| -57% | -$258K | ﹤0.01% | 1611 |
|
|
2019
Q4 | $657K | Buy |
+4,135
| New | +$657K | ﹤0.01% | 1596 |
|
|
2018
Q4 | – | Sell |
-1,736
| Closed | -$282K | – | 2456 |
|
|
2018
Q3 | $282K | Buy |
+1,736
| New | +$282K | ﹤0.01% | 1766 |
|